INTRODUCTION
Fine-needle aspiration (FNA) biopsy is a well established diagnostic tool for evaluating lesions in the salivary gland. In general, FNA has high accuracy in distinguishing non-neoplastic from neoplastic salivary gland lesions and low-grade from high-grade malignant salivary gland tumors. 1, 23 However, given the wide diversity of salivary gland tumors, false-negative and false-positive results do occur. 4 Because of the diagnostic difficulties of certain salivary gland lesions on FNA cytology, a standard reporting system is lacking. Recently, the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) has proposed a 6-category diagnostic classification scheme: nondiagnostic; non-neoplastic; atypia of undetermined significance; neoplasm, including benign neoplasm and neoplasm of uncertain malignant potential (NUMP); suspicious for malignancy; and malignant. 5, 6 Although the general diagnostic categories and criteria of the MSRSGC have been presented worldwide over the past 2 years, detailed criteria for each category still need to be refined. 7 NUMP usually applies to salivary gland neoplasms without clear distinction between benign and malignant. This category is problematic in terms of cytology interpretation and subsequent clinical management and thus is the focus of the current study. It is our anecdotal experience that most salivary gland FNAs in the NUMP category are from the following 2 distinctive groups based on a pattern-based approach: 1) basaloid neoplasm with scant myoepithelial stroma (BN) and 2) salivary gland neoplasm with a predominant oncocytic cell component (SGNOC). The objectives of the current study were: 1) to retrospectively review salivary gland FNA cases over a 6-year period in 2 large, tertiary medical centers; 2) to apply the MSRSGC to cases that potentially may fall into the NUMP category; 3) to identify the cases of NUMP that had histologic follow-up; and 4) to calculate the risk of malignancy (ROM) of NUMP and its subgroups.
MATERIALS AND METHODS
This retrospective cytohistologic correlation study was approved by the Geisinger Medical Center and Mayo Clinic Arizona institutional review boards. From January 2010 to December 2016, a computer search for patients with salivary gland FNA was conducted in the pathology database of Mayo Clinic Arizona and Geisinger Health System. Major or minor salivary gland lesions from these patients were aspirated using a direct percutaneous or transoral route with a 23-gauge or 25-gauge needle by trained surgeons, cytopathologists, or radiologists. The FNAs performed by radiologists were under the guidance of ultrasound, and the FNAs performed by surgeons or cytopathologists were guided by palpation. Smears were stained with Diff-Quick and Papanicolaou stains. Liquidbased cytology slides (ThinPrep; Hologic Inc, Marlborough, MA) were stained only with Papanicolaou stain.
Both institutions were using similar descriptive diagnostic terminologies for cases that potentially fell into the NUMP category. The FNA diagnoses were screened, and cases with the diagnostic terminology of "salivary gland neoplasm, but cannot exclude malignancy" or "salivary gland neoplasm, suspicious for malignancy" were selected. To prevent missing cases in the NUMP category, cases that had the diagnostic word "atypical" also were searched. These cases were reviewed and reclassified as according to the MSRSGC. The NUMP cases were identified and further subclassified into 2 morphologic groups of BN and SGNOC. The cytologic criteria for BN were: 1) cellular basaloid epithelial proliferation with scant or without myoepithelial stroma; and 2) lack of significant cytological atypia, necrosis, or increased mitoses. The cytologic criteria for SGNOC were: 1) cellular proliferation of oncocytic epithelial cells; 2) oncocytic epithelial cells that lack significant cytologic atypia; and 3) lack of cyst contents, appreciable inflammatory cells, or necrosis in the background. Cases that had definitive cytologic features of pleomorphic adenoma or Warthin tumor were excluded from the study.
Histology follow-up (surgical resection) of the NUMP cases was evaluated and tabulated. The ROMs of the general category of NUMP and of the 2 distinctive morphologic subgroups were calculated. Statistical comparisons were performed using the Fisher exact test based on 2 3 2 contingency tables. Calculations were conducted using the SAS statistical software package (SAS Institute Inc, Cary, NC).
RESULTS
From January 2010 to December 2016, in total, 656 salivary gland FNA cases (178 from Mayo Clinic Arizona and 478 from Geisinger Health System) were retrieved from the pathology database archives. A natural language search of "salivary gland neoplasm, low grade, but cannot exclude malignancy" or "salivary gland neoplasm, suspicious for malignancy" generated 78 cases (11.8%). Fifty-four of the 78 cases had histologic follow-up in the form of surgical resection specimens, which included 40 from the parotid gland, 11 from the submandibular gland, and 3 from the minor salivary glands. The other 24 cases were missing follow-up data and thus were not included in the final analysis.
FNA slides from the 54 cases with histologic followup were reviewed by 3 cytopathologists (H.L., M.A.Z., and L.C.) and confirmed the classification of NUMP according to the MSRSGC. The cytologic features of BN were: 1) cellular basaloid epithelial proliferation with scant or no myoepithelial stroma; and 2) lack of significant cytologic atypia, necrosis, or increased mitoses. The cytologic features of SGNOC were: 1) cellular proliferation of oncocytic epithelial cells; 2) oncocytic epithelial cells that lacked significant cytological atypia; and 3) lack of cyst contents, appreciable inflammatory cells, or necrosis in the background. These 54 cases were further evaluated for their cytologic characteristics using a pattern-based approach, with 29 placed in the BN subgroup and 25 placed in the SGNOC subgroup.
The histologic follow-up of the BN group revealed 14 cellular pleomorphic adenomas (PAs), 5 basal cell adenomas (BCAs), 2 benign cystadenomas, 3 adenoid cystic carcinomas (ADCCs), 3 epithelial and myoepithelial carcinomas (EMCAs), 1 basal cell adenocarcinoma (BCAC), and 1 myoepithelial carcinoma (MC). The histologic follow-up of the SGNOC group revealed 7 nodular oncocytoses, 6 Warthin tumors, 5 oncocytomas, 1 sebaceous adenoma, 1 mucinous cystadenoma, 2 acinic cell carcinomas (ACCs), 2 mucoepidermoid carcinomas (MECs), and 1 mammary analog secretory carcinoma (M) ( Table 1) . The cytohistologic correlation of the 54 NUMP cases is summarized in Table 1 . Representative cases of FNA cytology and follow-up surgical pathology are illustrated in Figures 1 through 4. The ROM was calculated as 24.1% (13 of 54 cases) for NUMP overall, 27.6% (8 of 29 cases) for the BN subgroup, and 20.0% (5 of 25 cases) for the SGNOC subgroup. Although the ROM of the BN subgroup was higher than that in the SGNOC subgroup, it was not statistically significant (P 5 .1).
DISCUSSION
Given the wide variety of tumors and the overlapping cytomorphologic features of many benign and low-grade malignant tumors of the salivary gland, descriptive diagnoses are common practice. Standardized terminology for reporting salivary gland FNA is lacking. 2, 3, 8 At the 2015
European Congress of Cytology held in Milan, Italy, a group of experienced cytopathologists initiated their efforts to create a unified salivary gland FNA reporting system. Later, the American Society of Cytopathology and the International Academy of Cytology organized an international panel of cytopathologists and surgical pathologists to establish a classification scheme for reporting salivary gland FNA. This classification scheme is under the title of the "Milan System for Reporting Salivary Gland Cytopathology (MSRSGC)." The MSRSGC has proposed the following 6-category diagnostic classifications: nondiagnostic; non-neoplastic; atypia of undetermined significance; neoplasm, including benign neoplasm and neoplasm of uncertain malignant potential (NUMP); suspicious for malignancy; and malignant. 5, 6 The ROMs associated with each category are summarized in Table 2 . 7 The goal of the MSRSGC is to provide an evidence-based, tiered classification system for risk assessment and better guidance for clinical management. The NUMP category under the MSRSGC is especially problematic and diagnostically challenging. In general, cases in the NUMP category are those confirmed as neoplasms by FNA, but cytology cannot exclude the possibility of low-grade malignant malignancies. 6 When the Milan group conducted the initial survey, this category was under "lesions of uncertain malignant potential." The survey respondents exhibited significant variation, subjectivity, and a great deal of apprehension of the NUMP category because of difficulty in interpretation. 6 BN was included in that survey and caused significant discussion among the Milan group regarding how these lesions should be incorporated into the MSRSGC. A previous study by 1 of our authors indicated that the majority of basaloid neoplasms had scant myoepithelial stroma. 9 It is well known that many salivary gland benign and malignant tumors have at least partial myoepithelial differentiation, including, but not limited to, cellular PA, myoepithelioma, BCA, and BCAC, etc. 10 The histologic follow-up data for the BN subgroup in this study again revealed a wide variety of tumors with scant myoepithelial stroma, including 14 cellular PAs, 5 BCAs, 2 benign cystadenomas, 3 EMCAs, 3
ADCCs, 1 BCAC, and 1 MC. Although the most of these are benign neoplasms, 27.6% of cases in the BN subgroup were malignant tumors. This finding is quite similar to that of by Chen et al, who reported a ROM of 30.0% (6 of 20 cases). 9 In a recent study by Rohilla et al, the ROM for the NUMP category was 50%; however, there were only 2 of those cases belonged to the NUMP category.
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In the current study, 14 of 29 BN cases were cellular PAs on histologic follow-up, as expected, because PA is the most common neoplasm of the salivary glands. The cytologic diagnosis of PA is usually straightforward if the classic abundant chondromyxoid stroma is sampled. 12 However, the diagnosis of PA becomes challenging when only scant myoepithelial stroma is present on FNA cytology slides. 13 Elsheikh and Bernacki studied 11 FNA cases of cellular PA and observed that a definitive diagnosis of PA could not be made on any case because of overlapping cytologic features among BCAs, ADCCs, and MCs. 14 The malignant neoplasms identified on histology follow-up in our study included 3 EMCAs, 3 ADCCs, 1 BCAC, and 1 MC. The FNA specimens from these cases revealed no significant (Fig. 1) . Several studies have reported similar cases in which the characteristic cytology features of ADCC were lacking in the FNA samples, making the distinction of ADCC from its mimics challenging, if not impossible. 9, 15, 16 The 3 EMCAs in our study were comprised mainly of an epithelial component with a minor component of myoepithelial cells. All 3 had scant myoepithelial stroma without significant cytologic atypia or necrosis (Fig. 2) . A few studies also have indicated that there were no distinctive or characteristic cytologic features for EMCA; thus a definitive diagnosis of EMCA was often unable to be rendered on FNA specimens. 17, 18 The current study included 1 BCAC and 1 MC on histologic follow-up. Although basal cell neoplasm and myoepithelial neoplasm were suspected on FNA cytology, in general, FNA is not reliable for distinguishing either BCAC from BCA or MC from myoepithelioma on cytology. 19 In summary, our data from the BN subgroup support the proposal by the MSRSGC that the "basaloid neoplasm" represents a subgroup within the category of NUMP. The other group of neoplasms that poses challenges in distinguishing between benign and low-grade malignancy is the group of neoplasms with predominant oncocytic cells (SGNOCs). The classic benign neoplasms comprised of oncocytes are Warthin tumors. When FNA samples reveal the typical bland oncocytes, lymphocytes, and cyst contents, the diagnosis of Warthin tumor is straightforward. 20 However, if the aspirates contain mostly oncocytic cells without appreciable lymphocytes or cyst contents, then the differential diagnoses become challenging. Under those circumstances, the possibility of several salivary gland neoplasms with oncocytic cells, such as nodular oncocytosis, oncocytoma, oncocytic carcinoma, ACC, an oncocytic variant of MEC, and even MASC, need to be considered. Our histologic follow-up of this subgroup revealed 20 benign lesions, including 7 nodular oncocytoses, 6 Warthin tumors, 5 oncocytomas, 1 sebaceous adenoma, and 1 mucinous cystadenoma. The finding of a significant number of nodular oncocytosis was unexpected. Nodular oncocytosis is not a neoplastic lesion; however, the cytologic findings are the same as what should be observed in an oncocytoma or Warthin tumor with a predominant oncocytic cell component. It is debatable whether this group of lesions should be classified as atypia of undetermined significance, as proposed by the MSRSGC. The mucinous cystadenoma in our study had a significant level of oncocytic metaplasia on histology, which contributed to its classification as SGNOC under NUMP. Five of 25 cases (20.0%) in this subgroup turned out to be malignant on surgical resection, which included 2 MECs, 2 ACCs, and 1 MASC. Both MECs were the oncocytic variant. Upon reviewing the cytology smears, both lesions had a predominant oncocytic cell component without mucinous cells. One had some intermediate cells, and the other had few squamoid cells. Although the presence of mucin can be helpful to differentiate Warthin tumor from MEC, as suggested in 1 study, 21 our cases again illustrated the difficulties in making a definitive diagnosis of oncocytic variant of MEC without mucinous cells. Mistaking ACCs with other salivary gland oncocytic neoplasms is a common cytologic pitfall. 22 ACC cells tend to have more delicate and vacuolated cytoplasm without defined cell borders; whereas oncocytes typically have coarse, granular cytoplasm and well defined cell borders. However, the distinctive cytologic features are often altered by other factors, such as preparation of the FNA specimens and characteristics of individual tumors. Often, a definitive cytologic diagnosis of ACC requires immunostains on cell blocks. Both of the ACCs in our study had more "oncocytic appearing" cells on the smears. ACC was considered; however, the lack of cell-block materials prevented further workup (Fig. 3) . One case of MASC is worth to mention. MASC is a relatively newly described malignant salivary gland neoplasm that can be very difficult to diagnose on FNA cytology. 23 Our case of MASC was a parotid gland FNA sample from a woman aged 66 years. The FNA smears were cellular, comprised of loose clusters and sheets of relatively uniform oncocytic cells with vacuolated cytoplasm (Fig. 4A-C) . Cell-block materials were insufficient for further study. The case was signed out as salivary gland neoplasm with oncocytic features. The follow-up surgical resection confirmed the diagnosis of MASC by immunohistochemistry and positive fluorescent in situ hybridization study for the ETS variant 6-neurotrophic receptor tyrosine kinase 3 (ETV6-NTRK3) translocation (Fig. 4D-F) . On FNA, MASC can reveal papillary/sheetlike neoplastic cells or small clusters of single neoplastic cells. Our results concur with a few published studies that a definitive diagnosis of MASC is often made on histology with the help of immunohistochemistry and fluorescent in situ hybridization. 24, 25 The ROM in our study (24.1%) appears to be significantly lower than the ROM of 35% for the NUMP category proposed by the MSRSGC (Table 2 ). This finding was not expected. Given the limited number of cases (n 5 54) of NUMP in our study, a potential selection bias may have caused the lower ROM. To the best of our knowledge, the ROM of the NUMP category is not well established. In a recent multi-institutional, interobserver variability study using a reporting system similar to that of the MSRSGC, Griffith et al 26 suggested that the patternbased risk-stratification scheme may be especially useful for the NUMP category, because the reported ROM for NUMP might be broad. Those authors reported much higher ROMs for "basaloid neoplasm with nonfibrillary stroma" (68.8%) and "oncocytic neoplasm with cystic/ other background" (33.3%). However, they had fewer cases (16 BNs and 9 SGNOCs) than we did, which may have contributed to their higher ROMs. In a recent metaanalysis by Wei et al using the MSRSGC reporting system, the ROM of the NUMP category was calculated at 37.5%. However, in that study, there were only 64 cases of NUMP from a total of 29 studies pooled for the metaanalysis. 27 Our study has limitations. First, NUMP is not a common diagnosis (11.8% of salivary gland FNA diagnoses), and only 54 cases with surgical pathology follow-up were studied. Second, a significant number of cases (30.7%) had no follow-up data. The above limitations may explain the significantly lower ROM in our study compared with the proposed rate for the NUMP category by the MSRSGC.
In summary, we reported a large cohort of salivary gland FNA cases of NUMP according to the MSRSGC. Our data indicated that the ROM for the SGNOC subgroup is similar to that for the BN subgroup, but the ROM for the NUMP group (24.1%) is lower than what was proposed by the MSRSGC (35%). Future studies with larger numbers of NUMP cases are needed to better establish the ROM of this intriguing group of salivary gland neoplasms.
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